Literature DB >> 27957042

Exploring The Obesity Paradox In Atrial Fibrillation. AFBAR (Atrial Fibrillation Barbanza Area) Registry Results.

M Cristina González-Cambeiro1, Emad Abu-Assi1, Sergio Raposeiras-Roubín1, Moisés Rodríguez-Mañero1, Fernando Otero-Raviña2, José R González-Juanatey1, Genaro Gutiérrez-Fernández3, Rosa Liñares-Stolle4, Jorge Alvear-García5, Mª Jesús Eirís-Cambre6, Carmen Cerqueiras-Alcalde7, Mª José Vázquez López5, Ángel Lado-Llerena8.   

Abstract

INTRODUCTION AND
OBJECTIVES: Previous studies have described an inverse relationship between obesity and adverse events in a variety of conditions. Our aim was to investigate the relationship between obesity and prognosis in patients with atrial fibrillation.
METHODS: We studied 746 patients who were prospectively included, between January and April 2008, in the AFBAR (Atrial Fibrillation in BARbanza area) registry. Patients were categorized into 3 body mass index groups using baseline measurements: normal (< 25 kg/m2), overweight (25-30 kg/m2), and obese (≥30 kg/m2). Survival free from the composite endpoint hospitalization for cardiovascular causes or all-cause mortality was compared across the 3 body mass index groups. A multivariable Cox proportional hazard regression was also performed to determine the independent effect of obesity as well as overweight, with respect to normal body mass index as a reference category, regarding the study endpoint. Median follow-up time was 36 (28-36) months.
RESULTS: 49.3% were obese and 38.2% had overweight. The composite endpoint rate was 70.9%, 67.5%, and 57.6% for obese, overweight, and normal weight patients, respectively (log rank test; p=0.02). An inverse association of obesity with a favorable prognosis persisted even after multivariable adjustment: hazard ratio 0.668; 95% confidence interval 0.449-0.995; p=0.047. Hazard ratio of overweight, however, was 0.741; 95% confidence interval: 0.500-1.098; p=0.096.
CONCLUSIONS: Obesity, defined as a body mass index ≥ 30 kg/m2, is associated with better prognosis in a community-based cohort of patients with atrial fibrillation.

Entities:  

Keywords:  Atrial fibrillation; Body Mass Index; Mortality; Prognosis

Year:  2014        PMID: 27957042      PMCID: PMC4956130          DOI: 10.4022/jafib.991

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  34 in total

1.  Obesity and outcomes among patients with established atrial fibrillation.

Authors:  Afrooz Ardestani; Heather J Hoffman; Howard A Cooper
Journal:  Am J Cardiol       Date:  2010-08-01       Impact factor: 2.778

2.  [SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria].

Authors:  Jordi Salas-Salvadó; Miguel A Rubio; Montserrat Barbany; Basilio Moreno
Journal:  Med Clin (Barc)       Date:  2007-02-10       Impact factor: 1.725

3.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.

Authors:  Gregg C Fonarow; Preethi Srikanthan; Maria Rosa Costanzo; Guillermo B Cintron; Margarita Lopatin
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

4.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Lone Juul Hune; Peter Vestergaard
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

Review 5.  Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies.

Authors:  Arthur R Menezes; Carl J Lavie; James J DiNicolantonio; James O'Keefe; Daniel P Morin; Sammy Khatib; Richard V Milani
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

6.  Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

Authors:  Wendy A Wattigney; George A Mensah; Janet B Croft
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

Review 7.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.

Authors:  Tim T Issac; Hisham Dokainish; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

8.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

9.  Relation of body fat categories by Gallagher classification and by continuous variables to mortality in patients with coronary heart disease.

Authors:  Alban De Schutter; Carl J Lavie; Dharmendrakumar A Patel; Surya M Artham; Richard V Milani
Journal:  Am J Cardiol       Date:  2012-12-19       Impact factor: 2.778

Review 10.  Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.

Authors:  Carl J Lavie; Martin A Alpert; Ross Arena; Mandeep R Mehra; Richard V Milani; Hector O Ventura
Journal:  JACC Heart Fail       Date:  2013-04-01       Impact factor: 12.035

View more
  3 in total

1.  Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure.

Authors:  Rosa M Agra-Bermejo; Rocio Gonzalez-Ferreiro; J Nicolos Lopez-Canoa; Alfonso Varela-Roman; Ines Gomez-Otero; Sonia Eiras; José R González-Juanatey
Journal:  J Cardiovasc Transl Res       Date:  2018-10-23       Impact factor: 4.132

Review 2.  Review Of Obesity And Atrial Fibrillation: Exploring The Paradox.

Authors:  González Cambeiro; María Cristina; Rodríguez Mañero; Raposeiras Roubin; Abu Assi; González Juanatey; José Ramón
Journal:  J Atr Fibrillation       Date:  2015-08-31

3.  Race, Body Mass Index, and the Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Matthew J Singleton; Charles A German; Mercedes Carnethon; Elsayed Z Soliman; Alain G Bertoni; Joseph Yeboah
Journal:  J Am Heart Assoc       Date:  2020-12-31       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.